National Association of Testing Authorities, Australia
Scope of Accreditation
Melbourne Pathology Pty Ltd
Sonic Healthcare Pty Ltd
Site
Melbourne Pathology Cabrini
Accreditation No.
2133
Site No.
2264
Date of Accreditation
30 Nov 1987
Contact
Mrs Louise Douglas
P: +61 (03) 92877716
Availability
Services available to external clients
Supervision
B (Branch)
Scope of Accreditation
Melbourne Pathology Cabrini
ISO 15189 (2012)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
17 Mar 2026
Last Activity Date
17 Sep 2021
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Cerebrospinal fluid (CSF); Pericardial fluid; Sputum; Synovial fluid; Urine; Vitreous specimens; Washings or brushings from other sites | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of nipple discharge or smears from squamous mucosal sites for the detection of cancerous or precancerous changes | Nipple discharge | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination; Rapid onsite evaluation (ROSE); Review and reporting of fine needle aspiration samples |
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin fixed tissue; Fresh tissue | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue | Intra-operative consultation and examination of biopsy material |
| Anatomical pathology - Tissue pathology - Immunohistochemical investigation | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of antigenic targets - Various |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Serum | Digoxin; Gentamicin (cidomycin, septopal, genticyn, garamycin); Methotrexate; Paracetamol (acetaminophen); Vancomycin |
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Serum | Parathyroid hormone (PTH) |
| Chemical pathology - Further investigation of cardiac function | Serum | B-type natriuretic peptide (BNP); Troponin |
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Serum | HDL - Quantitation |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Cerebrospinal fluid (CSF) | Glucose; Protein - Total |
| Plasma | Ammonia | |
| Serum | Alanine aminotransferase; Albumin; Alkaline phosphatase; Amylase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Chloride; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; Lactate; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urea; Uric acid; γ-Glutamyltransferase | |
| Serum; Urine | Osmolality | |
| Urine | Calcium - Total; Chloride; Creatinine; Glucose; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Urea; Uric acid | |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
| Haematology - Examination of blood films by special staining | Blood | Malaria |
| Haematology - Full blood examination | Blood | Morphology |
| Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Red blood cell index or indices; Reticulocytes | ||
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Plasma | Activated partial thromboplastin time (APTT) |
| Anti-Xa activity; D-dimer; Fibrinogen; International normalised ratio (INR); Prothrombin time (PT); Thrombin time (TT) | ||
| Heparin induced thrombotic thrombocytopenia (HITT) | ||
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Immunohaematology - Blood group antibody detection | Blood | Other blood group systems; Rh phenotypes |
| Immunohaematology - Blood grouping | Blood | ABO; RhD |
| Immunohaematology - Determination of compatibility of blood donor units | Blood | Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Other blood group antibodies; Red blood cell phenotyping; Rh |
| Antibody elution | ||
| Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Granulocytes; Platelets | Issue and release of blood and blood products for transfusion |
| Immunohaematology - Storage and distribution of blood and blood components | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Granulocytes; Platelets | Issue and release of blood and blood products for transfusion |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Serum | Cryofibrinogen; Cryoglobulins |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
| Infertility and pregnancy tests including assisted reproductive technology - Investigation of sperm | Semen | Sperm antibodies |
| Infertility and pregnancy tests including assisted reproductive technology - Semen analysis (other than post vasectomy) | Semen | pH |
| Volume | ||
| Colour; Liquefaction; Viscosity | ||
| Sperm number | ||
| Agglutination; Aggregation; Morphology; Motility; Vitality | ||
| Infertility and pregnancy tests including assisted reproductive technology - Semen analysis for post vasectomy and/or examination of cervical mucus | Semen | Presence of spermatozoa |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Blood; Cerebrospinal fluid (CSF); Ear swabs; Faeces; Fluids; General swabs; Genital swabs; Nasal swabs; Respiratory swabs and/or washings; Throat swabs; Tissues; Urine; Wound swabs | Bacteria; Pathogenic microorganisms |
| Aspirates; Blood; Cerebrospinal fluid (CSF); Ear swabs; Fluids; General swabs; Genital swabs; Nasal swabs; Respiratory swabs and/or washings; Throat swabs; Tissues; Urine; Wound swabs | Bacteria; Casts; Crystals; Eosinophils; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
| Bacterial isolates | Bacteria; Pathogenic identification and antibiotic susceptibility | |
| Blood | Bacteria; Pathogenic microorganisms | |
| Faeces | Clostridioides difficile | |
| Clostridioides difficile toxin | ||
| Urine | Bilirubin; Blood; Glucose; Ketones; Leucocyte esterase; Nitrite; Proteins; Specific gravity; Urobilinogen; pH | |
| Microbiology - Environmental investigations and/or infection control | Endoscopes; Environmental swabs; MRO screening swabs | Bacterial organism identification - Carbapenem resistant Enterobacteriaceae (CRE); Bacterial organism identification - Methicillin-resistant Staphylococcus aureus (MRSA); Bacterial organism identification - Vancomycin-resistant Enterococcus (VRE) |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Faeces; Rectal swabs | Carbapenem resistant Enterobacteriaceae (CRE); Vancomycin resistant Enterococci (VRE) |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Nasal swabs; Nasopharyngeal and throat swab; Nasopharyngeal swabs; Throat swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Nasopharyngeal aspirate; Nasopharyngeal swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) | |
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Biopsy specimens; Bronchial washings; Bronchoalveolar lavage; Sputum | Mycobacteria detection |
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Cerebrospinal fluid (CSF); Serum | Cryptococcus antigen |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
| Faeces | Cysts; Ova; Parasites | |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Blood | Infectious mononucleosis |
| Microbiology - Virology - Detection of pathogenic viruses | Faeces | Norovirus |
Emergency Department
ISO 15189 (2012)
Human Pathology
Medicare expiry date
17 Mar 2026
Last Activity Date
17 Sep 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised (pH corrected); Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Intensive Care Unit
ISO 15189 (2012)
Human Pathology
Medicare expiry date
17 Mar 2026
Last Activity Date
17 Sep 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Theatre
ISO 15189 (2012)
Human Pathology
Medicare expiry date
17 Mar 2026
Last Activity Date
17 Sep 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Chloride; Glucose; Haemoglobin (Hb); Lactate; Oxygen saturation (sO2); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2133
Site No.
2264
Print date
26 Apr 2024
END OF SCOPE
